Stock PHBI PHARMAGREEN BIOTECH INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Pharmagreen Biotech Inc.

Equities

PHBI

US71716C1099

Market Closed - OTC Markets
Other stock markets
 02:59:53 2024-07-11 pm EDT 		5-day change 1st Jan Change
0.00095 USD +18.75% Intraday chart for Pharmagreen Biotech Inc. -9.09% +66.67%
May. 20 Pharmagreen Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 CI
Feb. 21 Pharmagreen Biotech Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023 CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Pharmagreen Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024
CI
Pharmagreen Biotech Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023
CI
Pharmagreen Biotech Inc. Reports Earnings Results for the Full Year Ended September 30, 2023
CI
Pharmagreen Starts Sales of MaxGenomicTM Supplement on Amazon.Com and Develops Its Next Pre-Workout Formulation
CI
Pharmagreen Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023
CI
Pharmagreen Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023
CI
Pharmagreen Biotech Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022
CI
Pharmagreen Biotech, Inc. Launches Online Sales for Its MaxGenomic(TM) Supplement Product
CI
Pharmagreen Biotech Inc. Reports Earnings Results for the Full Year Ended September 30, 2022
CI
Pharmagreen Biotech Inc. Develops a Proprietary Nutraceutical Formulation and Prepares for Product Launch
CI
Pharmagreen Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022
CI
Pharmagreen Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022
CI
Pharmagreen Biotech Inc. Reports Earnings Results for the First Quarter Ended December 31, 2021
CI
Pharmagreen Biotech Inc. completed the acquisition of Long Valley Farms LLC.
CI
Pharmagreen Biotech Inc. Reports Earnings Results for the Full Year Ended September 30, 2021
CI
Pharmagreen Biotech Inc. Reports Earnings Results for the Third Quarter Ended June 30, 2021
CI
Pharmagreen Biotech Inc. entered into memorandum of understanding to acquire Long Valley Farms LLC for $2.4 million.
CI
Pharmagreen Biotech Inc. Reports Earnings Results for the Second Quarter Ended March 31, 2021
CI
Pharmagreen Biotech Inc. Signs LOI to Supply Crude CBD Oil Extracted from Certified Organically Grown Hemp Biomass
CI
Pharmagreen Biotech Inc. Reports Earnings Results for the Full Year Ended September 30, 2020
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PHBI Stock
  4. News Pharmagreen Biotech Inc.
  5. Highlights